ctrl K

Watchlist Price Alert

Acumen Pharmaceuticals In... (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

1.14

0.07 (6.54%)

At close: Jun 16, 2025, 3:59 PM

1.14

0.44%

After-hours: Jun 16, 2025, 04:04 PM EDT

Acumen Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	1.44M	1.7M
Cost of Revenue	n/a	42.32M	169K	4K	8K	8.58K
Gross Profit	n/a	-42.32M	-169K	-4K	1.43M	1.69M
Operating Income	-114.02M	-61.14M	-45.24M	-19.58M	-7.91M	-7.8M
Interest Income	14.32M	10.21M	2.39M	84K	1K	45K
Pretax Income	-102.33M	-52.37M	-42.86M	-100.61M	-7.33M	-7.91M
Net Income	-102.33M	-52.37M	-42.86M	-100.61M	-7.33M	-7.86M
Selling & General & Admin	20.22M	18.82M	12.88M	7.28M	1.35M	926K
Research & Development	93.8M	42.32M	32.36M	12.3M	8M	8.58M
Other Expenses	n/a	-42.32M	-11K	n/a	n/a	n/a
Operating Expenses	114.02M	61.14M	12.88M	19.58M	7.91M	9.5M
Interest Expense	4.07M	581K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	114.02M	61.14M	45.24M	19.58M	9.35M	9.5M
Income Tax Expense	n/a	n/a	-2.38M	81.07M	n/a	-45K
Shares Outstanding (Basic)	60.01M	48.49M	40.6M	20.06M	28.65M	40.15M
Shares Outstanding (Diluted)	60.01M	48.61M	40.6M	20.06M	28.65M	40.15M
EPS (Basic)	-1.71	-1.08	-1.06	-5.02	-0.26	-0.2
EPS (Diluted)	-1.71	-1.08	-1.06	-5.02	-0.26	-0.2
EBITDA	-98.08M	-51.61M	-42.69M	-19.58M	-7.91M	119K
EBIT	-98.26M	-51.79M	-42.86M	-19.58M	-7.91M	-7.8M
Depreciation & Amortization	178K	184K	169K	4K	n/a	7.8M